Cargando…
The rate of venous thromboembolism after knee bone marrow concentrate procedures: should we anticoagulate?
PURPOSE: Intra-articular injections of autologous, minimally manipulated, cell therapies such as bone marrow concentrate (BMC) to treat knee osteoarthritis (OA) may delay or prevent future total knee arthroplasty (TKA). Arthroplasty has the known and substantial risk of venous thromboembolism (VTE)...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492566/ https://www.ncbi.nlm.nih.gov/pubmed/35844014 http://dx.doi.org/10.1007/s00264-022-05500-3 |